Does type 2 diabetes influence the risk of oesophageal adenocarcinoma?

Mostrar otras versiones (1)

Since hyperinsulinaemia may promote obesity-linked cancers, we compared type 2 diabetes prevalence among oesophageal adenocarcinoma (OAC) patients and population controls. Diabetes increased the risk of OAC (adjusted odds ratio 1.59, 95% confidence interval (CI) 1.04–2.43), although the risk was att...

Descripción completa

Detalles Bibliográficos
Autores principales: Neale, R E, Doecke, J D, Pandeya, N, Sadhegi, S, Green, A C, Webb, P M, Whiteman, D C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653775/
https://www.ncbi.nlm.nih.gov/pubmed/19190630
http://dx.doi.org/10.1038/sj.bjc.6604908
_version_ 1782165314193063936
author Neale, R E
Doecke, J D
Pandeya, N
Sadhegi, S
Green, A C
Webb, P M
Whiteman, D C
author_facet Neale, R E
Doecke, J D
Pandeya, N
Sadhegi, S
Green, A C
Webb, P M
Whiteman, D C
author_sort Neale, R E
collection PubMed
description Since hyperinsulinaemia may promote obesity-linked cancers, we compared type 2 diabetes prevalence among oesophageal adenocarcinoma (OAC) patients and population controls. Diabetes increased the risk of OAC (adjusted odds ratio 1.59, 95% confidence interval (CI) 1.04–2.43), although the risk was attenuated after further adjusting for body mass index (1.32, 95% CI 0.85–2.05).
format Text
id pubmed-2653775
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-26537752010-03-10 Does type 2 diabetes influence the risk of oesophageal adenocarcinoma? Neale, R E Doecke, J D Pandeya, N Sadhegi, S Green, A C Webb, P M Whiteman, D C Br J Cancer Epidemiology Since hyperinsulinaemia may promote obesity-linked cancers, we compared type 2 diabetes prevalence among oesophageal adenocarcinoma (OAC) patients and population controls. Diabetes increased the risk of OAC (adjusted odds ratio 1.59, 95% confidence interval (CI) 1.04–2.43), although the risk was attenuated after further adjusting for body mass index (1.32, 95% CI 0.85–2.05). Nature Publishing Group 2009-03-10 2009-02-03 /pmc/articles/PMC2653775/ /pubmed/19190630 http://dx.doi.org/10.1038/sj.bjc.6604908 Text en Copyright © 2009 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Epidemiology
Neale, R E
Doecke, J D
Pandeya, N
Sadhegi, S
Green, A C
Webb, P M
Whiteman, D C
Does type 2 diabetes influence the risk of oesophageal adenocarcinoma?
title Does type 2 diabetes influence the risk of oesophageal adenocarcinoma?
title_full Does type 2 diabetes influence the risk of oesophageal adenocarcinoma?
title_fullStr Does type 2 diabetes influence the risk of oesophageal adenocarcinoma?
title_full_unstemmed Does type 2 diabetes influence the risk of oesophageal adenocarcinoma?
title_short Does type 2 diabetes influence the risk of oesophageal adenocarcinoma?
title_sort does type 2 diabetes influence the risk of oesophageal adenocarcinoma?
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653775/
https://www.ncbi.nlm.nih.gov/pubmed/19190630
http://dx.doi.org/10.1038/sj.bjc.6604908
work_keys_str_mv AT nealere doestype2diabetesinfluencetheriskofoesophagealadenocarcinoma
AT doeckejd doestype2diabetesinfluencetheriskofoesophagealadenocarcinoma
AT pandeyan doestype2diabetesinfluencetheriskofoesophagealadenocarcinoma
AT sadhegis doestype2diabetesinfluencetheriskofoesophagealadenocarcinoma
AT greenac doestype2diabetesinfluencetheriskofoesophagealadenocarcinoma
AT webbpm doestype2diabetesinfluencetheriskofoesophagealadenocarcinoma
AT whitemandc doestype2diabetesinfluencetheriskofoesophagealadenocarcinoma

Ejemplares similares